Abstract
Objectives
The lung injury is often secondary to severe trauma. In the model of crush syndrome, there may be secondary lung injury. We hypothesize that high-mobility group box 1 (HMGB1), released from muscle tissue, mediates the apoptosis of alveolar epithelial cells (AEC) via HMGB1/Receptor of advanced glycation end-products (RAGE)/c-Jun N-terminal kinase (JNK) pathway. The study aimed to investigate how HMGB1 mediated the apoptosis of AEC in the rat model.
Methods
Seventy-five SD male rats were randomly divided into five groups: CS, CS + vehicle, CS + Ethyl pyruvate (EP), CS + FPS-ZM1 group, and CS + SP600125 groups. When the rats CS model were completed after 24 h, the rats were sacrificed. We collected the serum and the whole lung tissues. Inflammatory cytokines were measured in serum samples. Western blot and RT-qPCR were used to quantify the protein and mRNA. Lastly, apoptotic cells were detected by TUNEL. We used SPSS 25.0 for statistical analyses.
Results
Nine rats died during the experiments. Dead rats were excluded from further analysis. Compared to the CS group, levels of HMGB1 and inflammatory cytokines in serum were downregulated in CS + EP, CS + FPS-ZM1, and CS + SP600125 groups. Western blot and RT-qPCR analysis revealed a significant downregulation of HMGB1, RAGE, and phosphorylated-JNK in CS + EP, CS + FPS-ZM1, and CS + SP600125 groups, compared with the CS groups, excluding total-JNK mRNA. Apoptosis of AEC was used TUNEL to assess. We found the TUNEL-positive cells were downregulated in CS + EP, CS + FPS-ZM1, and CS + SP600125 groups.
Conclusion
The remote lung injury begins early after crush injuries. The HMGB1/RAGE/JNK signaling axis is an attractive target to abrogate the apoptosis of AEC after crush injuries.
Keywords: Crush injury, High-mobility group box-1, Receptor of advanced glycation end-products (RAGE), c-Jun N-terminal kinase (JNK), SP600125, Apoptosis, Alveolar epithelial cells
Introduction
Crush injuries are severe soft tissues damage in the field of orthopedic trauma. Prolonged compression of limb muscles and subsequent decompression is essential in the development of crush syndrome (CS) [1], including hyperkalemia, metabolic acidosis, hypovolemic shock, acute kidney injury, and disseminated intravascular coagulation [2]. The sequential damage in the kidney after crush injury is not the unique dysfunctional organ [3]. It has been proved that the secondary damage in the lung [4–6], heart [7], and liver [8] contributes to multiple organs failure [9]. In fact, the pathophysiology following CS is a procedure of systemic inflammatory introducing injuries.
The lung injury has been observed clinically after severe trauma. This lung injury is secondary to the trauma, and likely due to an elevation in leukocytes and inflammatory cytokines in the lung tissue [10]. Duration of the treatment of trauma and the lung injury is often paid attention to when finding worse pulmonary function. It may be that the lung injury begins at the time of decompression. Therefore, we should notice that the remote lung injury at the early stage.
Currently, numerous studies have focused on a proinflammatory mediator, high-mobility group box 1 (HMGB1) [11–13]. In the model of CS, the levels of HMGB1 in muscle increased to peak at 12 h after decompression in the mice model [14]. In addition, the administration of anti-HMGB1 antibody improves survival rate and suppresses serum levels of HMGB1 and inflammation cytokines [6]. Significantly, the treatment for HMGB1 could ameliorate lung injury [15, 16].
However, the relationship between extracellular HMGB1 and lung injury is uncertain in crush injuries. The previous study has shown that HMGB1 is released from muscle tissue in response to damage immediately, and the level of serum HMGB1 increases quickly after decompression in the rats model [6]. The HMGB1 can be passively released from damaged cells as a proinflammatory alarmin [17]. When released HMGB1 enters the systemic circulation, the sequential response in remote lung injury follows. The receptor of advanced glycation end-products (RAGE) is a cell surface transmembrane multiligand receptor, and it can bind a large variety of endogenous ligands, such as HMGB1, leading to its classification as a pattern recognition receptor [18]. In the LPS-induced lung injury, the injury was found via HMGB1-RAGE signaling in alveolar epithelial cells (AEC). In addition, c-Jun N-terminal kinase (JNK) is an essential transducing enzyme that is involved in apoptosis of AEC [19], and JNK inhibitor SP600125 could improve cell apoptosis in acute lung injury [20]. The RAGE/JNK pathway has also been proved in participating the inflammation response [21].
Thus, we hypothesize that HMGB1, released from muscle tissue, mediates the apoptosis of AEC via the HMGB1/RAGE/JNK pathway. This study aimed to investigate the hypothesis via different inhibitors in the rats model.
Materials and methods
Animals
Seventy-five SD male rats weighing 250–300 g were purchased from the Laboratory Animal Center of Xi’an Jiaotong University. All animal procedures followed the ARRIVE guidelines [22] and the National Institutes of Health guide for the care and use of laboratory animals [23]. The Ethics Committee approved the study of Honghui Hospital, Xi’an Jiaotong University (2018025).
Treatment
The rats were housed and fed in a temperature of 22 ± 1 °C and humidity 45–55% environment with a standardized light–dark cycle (12 h day/night), and they were free to eat and drink. After one week of adaptive feeding, they were randomly divided into five groups: CS group, CS + vehicle group, CS + Ethyl pyruvate (EP) group, CS + FPS-ZM1 group, and CS + SP600125 group. The concentration of ethyl pyruvate, FPS-ZM1, and SP600125 was 50 mg/kg, 5 mg/kg, and 15 mg/kg, respectively.
We injected the above drugs into the intraperitoneal cavity before compression 0.5 h and used DMSO as the vehicle. (The injection volume was 0.7 mL.) CS + vehicle group was injected with the same volume of DMSO as a negative control, and the CS group was used as a blank control.
Rats model of CS
After administering inhibitors 0.5 h, the SD rats were anesthetized by intraperitoneal injection of 3% sodium pentobarbital (30 mg/kg). After anesthesia, the rats were fixed in the prone position, and the hind limbs were compressed at 4.5 cm away from the ankles, with 20 kg [24] heavy for 3 h. Because the mortality was high when compressing 6 h in a preliminary study, we chose to compress 3 h. The body temperature of the rats was maintained at 37 ± 0.5 °C during this period. After the compression was removed, the rats were allowed to recover for 24 h. When the recovery time was up to 24 h, the blood of rats was collected, the serum was separated, and then the rats were sacrificed. We collected the whole lung tissue and divided each lung tissue into two parts: one part of the lung tissue was stored in liquid nitrogen, and the other part of the lung tissue was fixed with 4% paraformaldehyde solution for later use.
ELISA
All serum samples were tested for HMGB1 (FineTest, Wuhan, China), tumor necrosis factor-α (TNF-α) (Wanleibio, Shenyang, China), IL-1β (Wanleibio, Shenyang, China), and IL-6 (Wanleibio, Shenyang, China), using a rat ELISA kit. The ELISA assay was performed following the manufacturer's protocols. The optical density of each well was measured spectrophotometrically at 450 nm within 5 min after adding the stop solution using a microplate reader (ELX-800, BIOTEK, USA).
Western blot
The frozen tissue samples were solubilized in RIPA buffer on ice using a homogenizer. Samples (50 μg/lane) were separated on a sodium dodecyl sulfate–polyacrylamide gel 12% gel) and electrotransferred onto polyvinylidene fluoride membranes. After 2 h incubation in blocking solution (5% non-fat milk in 20 mM Tris–HCl, 150 mM NaCl, 0.1% Tween-20; TBST), the membranes were blotted with primary antibodies against HMGB1 (1:1000, A19529, ABclonal), RAGE (1:1000, AF5309, Affinity), p-JNK (1:500, WL01295, Wanleibio), JNK (1:500, WL01813, Wanleibio), or β-actin (1:500, Wanleibio) overnight at 4 °C. After extensive rinsing with TBST buffer, the blots were incubated with HRP-conjugated secondary antibodies (Abgent, San Diego, CA, USA). The density of the bands was analyzed by Quantity One software version 4.62 (Bio-Rad, USA).
Real-time qPCR
Total RNA from the rats’ lung tissues was extracted by TRIpure reagent (RP1001, BioTeke, China). A commercial reverse transcription system BeyoRT II M-MLV (D7160L, Beyotime Biotechnology, China) was used to synthesize cDNA from purified total RNA. qRT-PCR was conducted using SYBR Green (SY1020, Solarbio, China) on a thermocycler (Exicycler™ 96, BIONEER, Korea). The sequences of primers used are listed in Table 1. β-actin was used as an internal control for indicated genes. The relative expression of a target gene was determined by the 2−△△CT method (NANO 2000, Thermo, USA).
Table 1.
Sequences of primers (5′–3′)
Primer | Sequence | Primer length | Tm | Product length |
---|---|---|---|---|
HMGB1 F | TGACAAGGCTCGTTATGAAAG | 21 | 55.8 | 186 |
HMGB1 R | TTCTTCGCAACATCACCAAT | 20 | 56.2 | |
RAGE F | GACGGGACTCTTCACGCTTCG | 21 | 64.4 | 192 |
RAGE R | CCACCTTCAGGCTCAACCAAC | 21 | 61.8 | |
JNK F | GATTTGGAGGAGCGAACTAA | 20 | 54.7 | 161 |
JNK R | CTGCTGTCTGTATCCGAGGC | 20 | 58 | |
β-actin F | GGAGATTACTGCCCTGGCTCCTAGC | 25 | 60.1 | 155 |
β-actin R | GGCCGGACTCATCGTACTCCTGCTT | 25 | 62 |
TUNEL staining
We used a terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) reaction utilizing TUNEL Kit (WLA127a, Wanleibio, China) to detect apoptotic cells. The tissue sections were deparaffinized with xylene and treated with H2O2 to inactivate endogenous peroxidase. After washing with PBS, the following operations were completed in a dark room. The specimens were incubated in the red labeling reaction mixture containing terminal deoxynucleotidyl transferase. The sections were then counterstained with a blue DAPI solution (D106471, Aladdin-e, China). Finally, the fluorescence images were collected in a camera system (DP73, OLYMPUS, Japan).
Statistical analysis
SPSS 25.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analyses. All data were presented as mean ± SD. Comparisons among multiple groups were performed using ANOVA. Comparisons between the two groups were performed using the LSD test. P < 0.05 was considered statistically significant.
Results
Mortality rate and general observations
In total, nine rats died after the compression and administration of drugs during the experiments. The number of deaths was 2, 3, 1, 2, and 1 in CS, CS + vehicle, CS + EP, CS + FPS-ZM1, and CS + SP600125 groups, respectively. There was no significant difference in mortality rate (P = 0.778). Dead rats were excluded from further analysis. After the modeling, activities of rats reduced obviously, with both hind limbs prolapsing. In all living rats, we found injured skeletal muscles to be hemorrhagic and with edema.
The levels of HMGB1 and inflammatory cytokines in serum
When testing the levels of serum HMGB1, we found that there was no significant statistical difference between the CS group and CS + vehicle group. Compared to the CS group, the level of HMGB1 was downregulated in CS + EP, CS + FPS-ZM1, and CS + SP600125 groups (Fig. 1a).
Fig. 1.
EP, FPS-ZM1, and SP600125 affect the expression of HMGB1 and inflammatory cytokines in serum. Relative levels of HMGB1, TNF-α, IL-1β, and IL-6 were analyzed using ELISA kits. The HMGB1 and all inflammatory cytokines were lower in the later three pretreatment groups. Results were expressed as means ± SDs. The number of rats were 13, 12, 14, 13, and 14 in CS, CS + vehicle, CS + EP, CS + FPS-ZM1, and CS + SP600125 groups, respectively. Statistical significance: ns P ≥ 0.05, *P < 0.05 and **P < 0.01, versus CS group
As for the inflammatory cytokines of TNF-α, IL-1β, and IL-6, there was no significant difference between the CS and CS + vehicle groups. However, the levels of these cytokines were lower in CS + EP, CS + FPS-ZM1, and CS + SP600125 groups, compared to the CS group (Fig. 1b–d).
Effect of EP, FPS-ZM1, and SP600125 on the protein expression of HMGB1, RAGE, and JNK
Western blot analysis revealed a significant downregulation of HMGB1 in CS + EP, CS + FPS-ZM1, and CS + SP600125 groups, compared with the CS groups (Fig. 2a). As for the RAGE and p-JNK, there was also significant downregulation in CS + EP, CS + FPS-ZM1, and CS + SP600125 groups (Fig. 2b, c).
Fig. 2.
EP, FPS-ZM1, and SP600125 affect the expression of HMGB1, RAGE, and JNK in lung tissue. Relative levels of HMGB1, RAGE, and JNK were analyzed using Western blot. The HMGB1, RAGE, and p-JNK were lower in the later three pretreatment groups. Results were expressed as means ± SDs. The number of rats were 13, 12, 14, 13, and 14 in CS, CS + vehicle, CS + EP, CS + FPS-ZM1, and CS + SP600125 groups, respectively. Statistical significance: ns P ≥ 0.05, *P < 0.05 and **P < 0.01, versus CS group
Effect of EP, FPS-ZM1, and SP600125 on the mRNA expression of HMGB1, RAGE, and JNK
RT-qPCR analysis revealed a significant downregulation of HMGB1 and RAGE mRNA in CS + EP, CS + FPS-ZM1, and CS + SP600125 groups, compared with the CS groups (Fig. 3a, b). As for the mRNA expression of JNK, there was no difference in the five groups (Fig. 3c).
Fig. 3.
EP, FPS-ZM1, and SP600125 affect the mRNA expression of HMGB1, RAGE, and JNK in lung tissue. Relative levels of HMGB1, RAGE, and JNK were analyzed using RT-qPCR. The HMGB1, RAGE, and p-JNK were lower in the later three pretreatment groups. Results were expressed as means ± SDs. The number of rats were 13, 12, 14, 13, and 14 in CS, CS + vehicle, CS + EP, CS + FPS-ZM1, and CS + SP600125 groups, respectively. Statistical significance: ns P ≥ 0.05, *P < 0.05 and **P < 0.01, versus CS group
Apoptosis of AEC
We used TUNEL to assess the apoptosis of AEC. As shown in Fig. 4, most of the AEC were TUNEL-positive cells in CS and CS + vehicle groups, and the number of positive cells decreased in the other three groups. After the statistic, we found there was no significant difference between the CS and CS + vehicle groups (P > 0.05) and TUNEL-positive cells in CS + EP, CS + FPS-ZM1, and CS + SP600125 groups were lower than the CS group (P < 0.05).
Fig. 4.
EP, FPS-ZM1, and SP600125 affect TUNEL-positive cells in lung tissue. The TUNEL-positive cells in CS + EP, CS + FPS-ZM1, and CS + SP600125 groups were lower than the CS group. The number of rats were 13, 12, 14, 13, and 14 in CS, CS + vehicle, CS + EP, CS + FPS-ZM1, and CS + SP600125 groups, respectively. We collected five slices in every rat and randomly selected five magnified visions in every slice
Discussion
In clinical, the lung injury maybe start at the early stage after crush injuries. The surgeons should notice the dynamic changes in pulmonary function. There were two main reasons we designed this study. On the one hand, some animals had the amount of pink foam in the mouth and nose when making animal models. We highly suspect the occurrence of secondary lung injury in the crush injury. On the other hand, this signaling pathway has not been verified in CS animal models. Thus, we conducted this animal experiment. In this study, we explored the potential role of the HMGB1/RAGE/JNK pathway on apoptosis of AEC to show the damage to lung tissue under the model of crush injuries. Our results indicate the following main findings. Firstly, the HMGB1 in muscle is rapidly released to the systemic circulation, and the remote lung injury begins early after crush injuries. Secondly, the HMGB1/RAGE/JNK pathway is involved in the pathophysiology of lung injury following CS. Thirdly, inhibitors of HMGB1, RAGE, and JNK could alleviate the apoptosis of AEC and serum inflammatory cytokines.
In terms of animal modeling, we chose SD rats and compression for 3 h. There are two reasons. The first reason was the degree of muscle damage at 3 h was the same as those at 6 h in the preliminary experiment, but there were more necrotic cells at 6 h. The second reason was that the mortality rate of rats at 6 h was too high, nearly 70–80%. It meant requiring too many experimental animals. In particular, the survival animals may have the possibility of selection bias, which would affect the reliability of the experimental results.
As for the HMGB1, RAGE, and JNK signaling inhibitors, we have chosen EP, FPS-ZM1, and SP600125 for intervention. The role of EP was chelating Ca2+ directly and responsible for the suppression of HMGB1 [25]. EP has been used to abrogate the pathological effects of HMGB1 [25, 26]. FPS-ZM1 is a blood–brain-barrier permeant, tertiary amide compound which is a high-affinity RAGE-specific inhibitor, blocking Aβ binding to the V domain of RAGE [27]. FPS-ZM1 was often used to inhibit the role of RAGE in an animal experiment [28, 29]. Moreover, an inhibitor of JNK, SP600125 [20], has been widely used. Thus, these administrations were specific blocking drugs to the signaling axis. We chose to give the drugs into the intraperitoneal cavity before compression to ensure they completely play the role.
In terms of detection methods, we adopted western blot and RT-qPCR techniques for mechanism exploration. Since the protein and mRNA expression trends were similar, the experimental results were relatively reliable. In addition, TUNEL was used to detect apoptosis of AEC [30]. Thus, these methods were typical and reliable.
The HMGB1/RAGE/JNK pathway has been studied in some studies, and the role of this pathway has been established in dopaminergic neurons [31], degenerated human nucleus pulposus cells [32]. In this study, we have identified the signaling axis of HMGB1/RAGE/JNK in lung injury after CS. The HMGB1 in muscle was released to the systemic circulation. When HMGB1 arrived at the lung, the RAGE/JNK pathway in AEC was activated, and the pathophysiology of lung injury began. Lastly, apoptosis becomes one of the damaged types of AEC. Furthermore, the treatment of inhibiting or blocking the role of HMGB1 may moderate the lung injury.
However, there are some limitations to this study. Firstly, we could not confirm whether inflammatory cytokines are released from damaged muscle cells or a response from other cells. Secondly, it is uncertain whether the apoptotic cell type is AEC type I or II or both. The above shortcomings need to be further implemented in cell research.
Conclusions
The remote lung injury begins early after crush injuries. The HMGB1/RAGE/JNK signaling axis is an attractive target to abrogate the apoptosis of AEC after crush injuries.
Acknowledgements
Not applicable.
Abbreviations
- CS
Crush syndrome
- HMGB1
High-mobility group box-1 protein
- RAGE
Receptor of advanced glycation end-products
- JNK
C-Jun N-terminal kinase
- AEC
Alveolar epithelial cells
- TNF-α
Tumor necrosis factor-α
- TUNEL
Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling
Authors' contributions
B-F Z and Y-M Z conceived and designed the experiments. B-F Z, W S, J W, and P-F W performed the experiments. B-F Z analyzed the data. B-F Z wrote the manuscript. All authors read and approved the final manuscript.
Funding
This work was supported by the Natural Science Foundation of Shaanxi Province (Grant numbers 2020JQ-961).
Availability of data and material
Please contact author for data requests.
Declarations
Ethics approval and consent to participate
The study was approved by the Ethics Committee of Honghui Hospital, Xi'an Jiaotong University (No. 2018025).
Consent to publish
The work described has not been published before (except in the form of an abstract or as part of a published lecture, review, or thesis); it is not under consideration for publication elsewhere; and its publication has been approved by all co-authors.
Competing interests
The authors have declared that no competing interests exist.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Bin-Fei Zhang, Email: zhangbf07@gmail.com.
Wei Song, Email: songweibone@126.com.
Jun Wang, Email: jackey_886@163.com.
Peng-Fei Wen, Email: wenpengfei@pku.edu.cn.
Yu-Min Zhang, Email: zym2666@126.com.
References
- 1.Gonzalez D. Crush syndrome. Crit Care Med. 2005;33(1 Suppl):S34–41. doi: 10.1097/01.CCM.0000151065.13564.6F. [DOI] [PubMed] [Google Scholar]
- 2.Malinoski D, Slater M, Mullins R. Crush injury and rhabdomyolysis. Crit Care Clin. 2004;20(1):171–192. doi: 10.1016/S0749-0704(03)00091-5. [DOI] [PubMed] [Google Scholar]
- 3.Lv Q, Long M, Wang X, et al. The role of alpha-1-acid glycoprotein in the diagnosis and treatment of crush syndrome-induced acute kidney injury. Shock. 2021;56:1028. doi: 10.1097/SHK.0000000000001839. [DOI] [PubMed] [Google Scholar]
- 4.Sonoi H, Matsumoto N, Ogura H, et al. The effect of antithrombin on pulmonary endothelial damage induced by crush injury. Shock. 2009;32(6):593–600. doi: 10.1097/SHK.0b013e3181a23ad0. [DOI] [PubMed] [Google Scholar]
- 5.Nakagawa J, Matsumoto N, Nakane Y, et al. The Beneficial effects of ETS-GS, a novel Vitamin E derivative, on a rat model of crush injury. Shock. 2016;46(6):681–687. doi: 10.1097/SHK.0000000000000681. [DOI] [PubMed] [Google Scholar]
- 6.Shimazaki J, Matsumoto N, Ogura H, et al. Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury. Shock. 2012;37(6):634–638. doi: 10.1097/SHK.0b013e31824ed6b7. [DOI] [PubMed] [Google Scholar]
- 7.Liu S, Yu Y, Luo B, et al. Impact of traumatic muscle crush injury as a cause of cardiomyocyte-specific injury: an experimental study. Heart Lung Circ. 2013;22(4):284–290. doi: 10.1016/j.hlc.2012.11.008. [DOI] [PubMed] [Google Scholar]
- 8.Sgarbi M, Silva B, Peres C, et al. Leukocyte infiltration in lung, muscle, and liver after limb compression in rats. Pathophysiology. 2013;20(2):111–116. doi: 10.1016/j.pathophys.2012.12.001. [DOI] [PubMed] [Google Scholar]
- 9.Xu P, Wang F, Zhou X, et al. Systemic inflammatory response and multiple organ dysfunctions following crush injury: a new experimental model in rabbits. Inflammation. 2018;41(1):240–248. doi: 10.1007/s10753-017-0683-5. [DOI] [PubMed] [Google Scholar]
- 10.Wu X, Schwacha MG, Dubick MA, et al. Trauma-related acute lung injury develops rapidly irrespective of resuscitation strategy in the rat. Shock. 2016;46(3 Suppl 1):108–114. doi: 10.1097/SHK.0000000000000652. [DOI] [PubMed] [Google Scholar]
- 11.Yamamoto T, Ono T, Ito T, et al. Hemoperfusion with a high-mobility group box 1 adsorption column can prevent the occurrence of hepatic ischemia-reperfusion injury in rats. Crit Care Med. 2010;38(3):879–885. doi: 10.1097/CCM.0b013e3181c58951. [DOI] [PubMed] [Google Scholar]
- 12.Kang R, Zhang Q, Hou W, et al. Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology. 2014;146(4):1097–1107. doi: 10.1053/j.gastro.2013.12.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Andersson U, Ottestad W, Tracey K. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med. 2020;26(1):42. doi: 10.1186/s10020-020-00172-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Zhang B, Wang P, Cong Y, et al. Anti-high mobility group box-1 (HMGB1) antibody attenuates kidney damage following experimental crush injury and the possible role of the tumor necrosis factor-α and c-Jun N-terminal kinase pathway. J Orthop Surg Res. 2017;12(1):110. doi: 10.1186/s13018-017-0614-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wang M, Gauthier A, Daley L, et al. The role of HMGB1, a nuclear damage-associated molecular pattern molecule, in the pathogenesis of lung diseases. Antioxid Redox Signal. 2019;31(13):954–993. doi: 10.1089/ars.2019.7818. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Qu L, Chen C, Chen Y, et al. High-mobility Group Box 1 (HMGB1) and autophagy in acute lung injury (ALI): a review. Med Sci Monit. 2019;25:1828–1837. doi: 10.12659/MSM.912867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Scaffidi P, Misteli T, Bianchi M. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191–195. doi: 10.1038/nature00858. [DOI] [PubMed] [Google Scholar]
- 18.Oczypok E, Perkins T, Oury T. All the "RAGE" in lung disease: the receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses. Paediatr Respir Rev. 2017;23:40–49. doi: 10.1016/j.prrv.2017.03.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Fu Y, Fang F, Lu Z, et al. N-acetylcysteine protects alveolar epithelial cells from hydrogen peroxide-induced apoptosis through scavenging reactive oxygen species and suppressing c-Jun N-terminal kinase. Exp Lung Res. 2010;36(6):352–361. doi: 10.3109/01902141003678582. [DOI] [PubMed] [Google Scholar]
- 20.Shen H, Wu N, Wang Y, et al. JNK inhibitor SP600125 attenuates paraquat-induced acute lung injury: an in vivo and in vitro study. Inflammation. 2017;40(4):1319–1330. doi: 10.1007/s10753-017-0575-8. [DOI] [PubMed] [Google Scholar]
- 21.Wu X, Mi Y, Yang H, et al. The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-κB pathway. Mol Cell Biochem. 2013;380:249–257. doi: 10.1007/s11010-013-1680-0. [DOI] [PubMed] [Google Scholar]
- 22.Percie du Sert N, Ahluwalia A, Alam S, et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020;18(7):e3000411. doi: 10.1371/journal.pbio.3000411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Council NR. Guide for the care and use of laboratory animals. Washington, DC: The National Academies Press; 1996. [PubMed] [Google Scholar]
- 24.Fan BS, Zhang EH, Wu M, et al. Activation of alpha7 nicotinic acetylcholine receptor decreases on-site mortality in crush syndrome through insulin signaling-Na/K-ATPase pathway. Front Pharmacol. 2016;7:79. doi: 10.3389/fphar.2016.00079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Shin J, Kim I, Kim S, et al. Ethyl pyruvate inhibits HMGB1 phosphorylation and release by chelating calcium. Mol Med. 2015;20:649–657. doi: 10.2119/molmed.2014.00039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bhat S, Massey N, Karriker L, et al. Ethyl pyruvate reduces organic dust-induced airway inflammation by targeting HMGB1-RAGE signaling. Respir Res. 2019;20(1):27. doi: 10.1186/s12931-019-0992-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Zhou H, Jin C, Cui L, et al. HMGB1 contributes to the irradiation-induced endothelial barrier injury through receptor for advanced glycation endproducts (RAGE) J Cell Physiol. 2018;233(9):6714–6721. doi: 10.1002/jcp.26341. [DOI] [PubMed] [Google Scholar]
- 28.Liu Y, Shen W, Chen Q, et al. Inhibition of RAGE by FPS-ZM1 alleviates renal injury in spontaneously hypertensive rats. Eur J Pharmacol. 2020;882:173228. doi: 10.1016/j.ejphar.2020.173228. [DOI] [PubMed] [Google Scholar]
- 29.Deane R, Singh I, Sagare AP, et al. A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest. 2012;122(4):1377–1392. doi: 10.1172/JCI58642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Li J, Zhou Q, Liang Y, et al. miR-486 inhibits PM2.5-induced apoptosis and oxidative stress in human lung alveolar epithelial A549 cells. Ann Transl Med. 2018;6(11):209. doi: 10.21037/atm.2018.06.09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kim S, Ryu M, Han J, et al. Activation of the HMGB1-RAGE axis upregulates TH expression in dopaminergic neurons via JNK phosphorylation. Biochem Biophys Res Commun. 2017;493(1):358–364. doi: 10.1016/j.bbrc.2017.09.017. [DOI] [PubMed] [Google Scholar]
- 32.Niu C, Lin S, Yuan L, et al. Upregulation of miR-107 expression following hyperbaric oxygen treatment suppresses HMGB1/RAGE signaling in degenerated human nucleus pulposus cells. Arthritis Res Ther. 2019;21(1):42. doi: 10.1186/s13075-019-1830-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Please contact author for data requests.